Literature DB >> 17132212

Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.

Hrushikesh B Agashe1, Tathagata Dutta, Minakshi Garg, N K Jain.   

Abstract

Dendrimers have generated tremendous interest in the field of drug delivery. Despite indications of their utility as drug carriers, the inherent cytotoxicity associated with polycationic dendrimers acts as a limiting factor to their clinical applications. Many functionalization strategies have been adopted to mask peripheral amines in order to overcome this limitation. The object of the present investigation was to evaluate the effect of functionalization on the toxicological profile of fifth-generation poly(propylene imine) dendrimer (PPI-5.0G). Four forms of functionalized dendrimers, including protected glycine and phenylalanine, and mannose and lactose functionalized poly(propylene imine) (PPI) dendrimer, were synthesized as prospective drug carriers. These dendrimeric systems were evaluated for haemolytic toxicity, cytotoxicity, immunogenicity and haematological parameters. PPI-5.0G demonstrated a positive charge-based time- and concentration-dependent toxicity profile. Functionalization greatly improved the toxicity profile of the parent dendrimer. Hence it is proposed that these functionalized forms of PPI dendrimer have great potential as bio-compatible drug vehicles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132212     DOI: 10.1211/jpp.58.11.0010

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  32 in total

1.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

Review 2.  Nanoparticles and the immune system.

Authors:  Banu S Zolnik; Africa González-Fernández; Nakissa Sadrieh; Marina A Dobrovolskaia
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

Review 3.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Authors:  Marina A Dobrovolskaia; Parag Aggarwal; Jennifer B Hall; Scott E McNeil
Journal:  Mol Pharm       Date:  2008-05-30       Impact factor: 4.939

4.  Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting.

Authors:  Rahul Rattan; Somnath Bhattacharjee; Hong Zong; Corban Swain; Muneeb A Siddiqui; Scott H Visovatti; Yogendra Kanthi; Sajani Desai; David J Pinsky; Sascha N Goonewardena
Journal:  Bioorg Med Chem       Date:  2017-06-30       Impact factor: 3.641

5.  Agglomeration of Escherichia coli with Positively Charged Nanoparticles Can Lead to Artifacts in a Standard Caenorhabditis elegans Toxicity Assay.

Authors:  Shannon K Hanna; Antonio R Montoro Bustos; Alexander W Peterson; Vytas Reipa; Leona D Scanlan; Sanem Hosbas Coskun; Tae Joon Cho; Monique E Johnson; Vincent A Hackley; Bryant C Nelson; Michael R Winchester; John T Elliott; Elijah J Petersen
Journal:  Environ Sci Technol       Date:  2018-05-02       Impact factor: 9.028

Review 6.  Recent perspectives on the delivery of biologics to back of the eye.

Authors:  Mary Joseph; Hoang M Trinh; Kishore Cholkar; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2016-09-06       Impact factor: 6.648

7.  Synthesis and Characterization of Anionic Triazine Dendrimers with a Labile Disulfide Core.

Authors:  Wen Zhang; Sanjiv Lalwani; Abdellatif Chouai; Eric E Simanek
Journal:  Isr J Chem       Date:  2009-01-01       Impact factor: 3.333

Review 8.  Effects of nanomaterial physicochemical properties on in vivo toxicity.

Authors:  Kristin L Aillon; Yumei Xie; Nashwa El-Gendy; Cory J Berkland; M Laird Forrest
Journal:  Adv Drug Deliv Rev       Date:  2009-04-20       Impact factor: 15.470

Review 9.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

Review 10.  Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.

Authors:  Anna N Ilinskaya; Marina A Dobrovolskaia
Journal:  Toxicol Appl Pharmacol       Date:  2016-01-07       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.